• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于片段的基质金属蛋白酶-13 吲哚抑制剂的发现。

Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.

机构信息

Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, Connecticut 06877-0368, United States.

出版信息

J Med Chem. 2011 Dec 8;54(23):8174-87. doi: 10.1021/jm201129m. Epub 2011 Nov 9.

DOI:10.1021/jm201129m
PMID:22017539
Abstract

Matrix metalloproteases (MMPs) play an important role in cartilage homeostasis under both normal and inflamed disease states and, thus, have become attractive targets for the treatment of arthritic diseases. Herein, we describe the identification of a potent, selective MMP-13 inhibitor, developed using fragment-based structure-guided lead identification and optimization techniques. Virtual screening methods identified a novel, indole-based MMP-13 inhibitor that bound into the S1' pocket of the protein exhibiting a novel interaction pattern hitherto not observed in MMP-13 inhibitors. X-ray crystallographic structures were used to guide the elaboration of the fragment, ultimately leading to a potent inhibitor that was >100-fold selective over nine other MMP isoforms tested.

摘要

基质金属蛋白酶(MMPs)在正常和炎症疾病状态下的软骨动态平衡中发挥着重要作用,因此,它们已成为治疗关节炎疾病的有吸引力的靶标。在此,我们描述了一种使用基于片段的结构引导的先导识别和优化技术开发的强效、选择性 MMP-13 抑制剂的鉴定。虚拟筛选方法鉴定出一种新型吲哚基 MMP-13 抑制剂,该抑制剂结合到蛋白质的 S1'口袋中,表现出迄今为止在 MMP-13 抑制剂中未观察到的新型相互作用模式。X 射线晶体结构用于指导片段的阐述,最终导致一种强效抑制剂,对测试的其他 9 种 MMP 同工型具有 >100 倍的选择性。

相似文献

1
Fragment-based discovery of indole inhibitors of matrix metalloproteinase-13.基于片段的基质金属蛋白酶-13 吲哚抑制剂的发现。
J Med Chem. 2011 Dec 8;54(23):8174-87. doi: 10.1021/jm201129m. Epub 2011 Nov 9.
2
Discovery of potent, selective chymase inhibitors via fragment linking strategies.通过片段连接策略发现有效的、选择性的糜酶抑制剂。
J Med Chem. 2013 Jun 13;56(11):4465-81. doi: 10.1021/jm400138z. Epub 2013 Jun 4.
3
Potent inhibitors precise to S1' loop of MMP-13, a crucial target for osteoarthritis.强效抑制剂精准靶向 MMP-13 的 S1' 环,这是骨关节炎的关键靶点。
J Mol Graph Model. 2013 Jul;44:297-310. doi: 10.1016/j.jmgm.2013.06.005. Epub 2013 Jul 4.
4
Discovery of novel, highly potent, and selective quinazoline-2-carboxamide-based matrix metalloproteinase (MMP)-13 inhibitors without a zinc binding group using a structure-based design approach.基于结构的设计方法发现新型高活性和选择性喹唑啉-2-甲酰胺基质金属蛋白酶(MMP)-13 抑制剂,不含锌结合基团。
J Med Chem. 2014 Nov 13;57(21):8886-902. doi: 10.1021/jm500981k. Epub 2014 Oct 15.
5
Virtual High-Throughput Screening for Matrix Metalloproteinase Inhibitors.基质金属蛋白酶抑制剂的虚拟高通量筛选
Methods Mol Biol. 2017;1579:259-271. doi: 10.1007/978-1-4939-6863-3_14.
6
Thieno[2,3-d]pyrimidine-2-carboxamides bearing a carboxybenzene group at 5-position: highly potent, selective, and orally available MMP-13 inhibitors interacting with the S1″ binding site.在5-位带有羧基苯基团的噻吩并[2,3-d]嘧啶-2-甲酰胺:与S1″结合位点相互作用的高效、选择性且口服可用的基质金属蛋白酶-13抑制剂
Bioorg Med Chem. 2014 Oct 1;22(19):5487-505. doi: 10.1016/j.bmc.2014.07.025. Epub 2014 Aug 7.
7
Potent and selective 2-naphthylsulfonamide substituted hydroxamic acid inhibitors of matrix metalloproteinase-13.强效且选择性的基质金属蛋白酶-13 的 2-萘基磺酰胺取代羟肟酸抑制剂。
Bioorg Med Chem Lett. 2011 Nov 1;21(21):6440-5. doi: 10.1016/j.bmcl.2011.08.087. Epub 2011 Aug 27.
8
Structure-Based Design and Synthesis of Potent and Selective Matrix Metalloproteinase 13 Inhibitors.基于结构的强效和选择性基质金属蛋白酶13抑制剂的设计与合成
J Med Chem. 2017 Jul 13;60(13):5816-5825. doi: 10.1021/acs.jmedchem.7b00514. Epub 2017 Jun 27.
9
The intermediate S1' pocket of the endometase/matrilysin-2 active site revealed by enzyme inhibition kinetic studies, protein sequence analyses, and homology modeling.通过酶抑制动力学研究、蛋白质序列分析和同源性建模揭示的子宫内膜酶/基质溶素-2活性位点的中间S1'口袋。
J Biol Chem. 2003 Dec 19;278(51):51646-53. doi: 10.1074/jbc.M310109200. Epub 2003 Oct 7.
10
Design and synthesis of phosphinamide-based hydroxamic acids as inhibitors of matrix metalloproteinases.基于磷酰胺的异羟肟酸作为基质金属蛋白酶抑制剂的设计与合成
J Med Chem. 1999 Jan 14;42(1):87-94. doi: 10.1021/jm980142s.

引用本文的文献

1
Curcumin monoglucuronide protects cartilage from progressive degeneration by blocking MMP-13.姜黄素单葡萄糖醛酸苷通过阻断基质金属蛋白酶-13来保护软骨免受进行性退变。
Arch Pharm Res. 2025 Aug;48(7-8):765-781. doi: 10.1007/s12272-025-01558-w. Epub 2025 Jul 29.
2
Unveiling the therapeutic potential of leaves: Exploring antioxidant, anti-inflammatory, anti-arthritic, and cytotoxic activities through biological and molecular docking evaluation with DFT analysis.揭示树叶的治疗潜力:通过结合密度泛函理论(DFT)分析的生物学和分子对接评估来探索其抗氧化、抗炎、抗关节炎和细胞毒性活性。
Heliyon. 2024 Sep 26;10(19):e38541. doi: 10.1016/j.heliyon.2024.e38541. eCollection 2024 Oct 15.
3
Identification of -Acyl Hydrazones as New Non-Zinc-Binding MMP-13 Inhibitors by Structure-Based Virtual Screening Studies and Chemical Optimization.
基于结构的虚拟筛选研究和化学优化鉴定新型非锌结合 MMP-13 抑制剂 - 酰基酰肼。
Int J Mol Sci. 2023 Jul 4;24(13):11098. doi: 10.3390/ijms241311098.
4
Indole Inhibitors of MMP-13 for Arthritic Disorders.用于治疗关节炎疾病的基质金属蛋白酶-13吲哚抑制剂
ACS Omega. 2021 Jul 19;6(29):18635-18650. doi: 10.1021/acsomega.1c01320. eCollection 2021 Jul 27.
5
Digestive Inflammation: Role of Proteolytic Dysregulation.消化炎症:蛋白水解失调的作用。
Int J Mol Sci. 2021 Mar 10;22(6):2817. doi: 10.3390/ijms22062817.
6
Inhibition of hypertrophy and improving chondrocyte differentiation by MMP-13 inhibitor small molecule encapsulated in alginate-chondroitin sulfate-platelet lysate hydrogel.包被在藻酸盐-硫酸软骨素-血小板裂解物水凝胶中的 MMP-13 抑制剂小分子抑制肥大和改善软骨细胞分化。
Stem Cell Res Ther. 2020 Oct 9;11(1):436. doi: 10.1186/s13287-020-01930-1.
7
Fragment-Based Drug Design Facilitated by Protein-Templated Click Chemistry: Fragment Linking and Optimization of Inhibitors of the Aspartic Protease Endothiapepsin.基于蛋白质模板的点击化学促进的片段药物设计:天冬氨酸蛋白酶内切酶抑制剂的片段连接和优化。
Chemistry. 2016 Oct 10;22(42):14826-14830. doi: 10.1002/chem.201603001. Epub 2016 Sep 7.
8
Molecular Recognition of the Catalytic Zinc(II) Ion in MMP-13: Structure-Based Evolution of an Allosteric Inhibitor to Dual Binding Mode Inhibitors with Improved Lipophilic Ligand Efficiencies.基质金属蛋白酶-13中催化锌(II)离子的分子识别:基于结构的变构抑制剂向具有改善亲脂性配体效率的双结合模式抑制剂的进化。
Int J Mol Sci. 2016 Mar 1;17(3):314. doi: 10.3390/ijms17030314.
9
Merging allosteric and active site binding motifs: de novo generation of target selectivity and potency via natural-product-derived fragments.融合变构和活性位点结合基序:通过天然产物衍生片段从头生成靶点选择性和效力。
ChemMedChem. 2015 Mar;10(3):451-4. doi: 10.1002/cmdc.201402478. Epub 2014 Dec 8.
10
Strategic targeting of multiple water-mediated interactions: a concise and rational structure-based design approach to potent and selective MMP-13 inhibitors.多种水介导相互作用的策略性靶向:一种简洁且合理的基于结构的强效和选择性基质金属蛋白酶-13抑制剂设计方法。
ChemMedChem. 2013 Sep;8(9):1457-61, 1572. doi: 10.1002/cmdc.201300278. Epub 2013 Jul 26.